Literature DB >> 12377823

Rifampicin and treatment of cholestatic pruritus.

A F Hofmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12377823      PMCID: PMC1773428          DOI: 10.1136/gut.51.5.756

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Intermittent external biliary drainage for relief of pruritus in certain chronic disorders of the liver.

Authors:  R L VARCO
Journal:  Surgery       Date:  1947-01       Impact factor: 3.982

2.  [The effects of biliary drainage in cholestatic hepatitis].

Authors:  P M Huet; M Rautureau; D Dhumeaux; J Caroli
Journal:  Rev Med Chir Mal Foie       Date:  1970

3.  Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids.

Authors:  C Di Padova; R Tritapepe; P Rovagnati; S Rossetti
Journal:  Methods Find Exp Clin Pharmacol       Date:  1984-12

4.  Ileal exclusion for Byler's disease: an alternative surgical approach with promising early results for pruritus.

Authors:  C M Hollands; F J Rivera-Pedrogo; R Gonzalez-Vallina; O Loret-de-Mola; M Nahmad; C A Burnweit
Journal:  J Pediatr Surg       Date:  1998-02       Impact factor: 2.545

5.  The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers.

Authors:  Jan Stange; Tarek I Hassanein; Ravindra Mehta; Steffen R Mitzner; Robert H Bartlett
Journal:  Artif Organs       Date:  2002-02       Impact factor: 3.094

6.  Treatment of pruritus in cholestatic jaundice by bilirubin- and bile acid-adsorbing resin column plasma perfusion.

Authors:  A A Alarabi; B Wikström; L Lööf; B G Danielson
Journal:  Scand J Gastroenterol       Date:  1992       Impact factor: 2.423

7.  Stimulation of bile acid 6 alpha-hydroxylation by rifampin.

Authors:  H Wietholtz; H U Marschall; J Sjövall; S Matern
Journal:  J Hepatol       Date:  1996-06       Impact factor: 25.083

8.  Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.

Authors:  P Ricci; A F Hofmann; L R Hagey; R A Jorgensen; E Rolland Dickson; K D Lindor
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

  8 in total
  7 in total

1.  Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Drug Metab Dispos       Date:  2006-02-02       Impact factor: 3.922

2.  MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus.

Authors:  James Meixiong; Chirag Vasavda; Solomon H Snyder; Xinzhong Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-08       Impact factor: 11.205

3.  Expression dynamics of pregnane X receptor-controlled genes in 3D primary human hepatocyte spheroids.

Authors:  Tomas Smutny; Veronika Bernhauerova; Lucie Smutna; Jurjen Duintjer Tebbens; Petr Pavek
Journal:  Arch Toxicol       Date:  2021-10-23       Impact factor: 5.153

Review 4.  Nuclear receptors in bile acid metabolism.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

Review 5.  Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer.

Authors:  Tiangang Li; Udayan Apte
Journal:  Adv Pharmacol       Date:  2015-05-27

Review 6.  Bile acid signaling in metabolic disease and drug therapy.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

Review 7.  Alagille Syndrome: Diagnostic Challenges and Advances in Management.

Authors:  Mohammed D Ayoub; Binita M Kamath
Journal:  Diagnostics (Basel)       Date:  2020-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.